39
Participants
Start Date
September 30, 2012
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
nab-Paclitaxel
Abraxane: 150mg/m2 i.v weekly for 3 consecutive weeks followed by a week of rest (28d)
University Hospital of Crete, Dep of Medical Oncology Heraklion, Greece, Heraklion
"Laikon General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine", Athens
Air Forces Military Hospital of Athens Athens, Greece, Athens
SOTIRIA Hospital, Medical Oncology Department, Athens
"Ag. Georgios General Hospital of Chania", Chania
"PAPAGEORGIOY General Hospital of Thessaloniki", Thessaloniki
Lead Sponsor
Hellenic Oncology Research Group
OTHER